Research Article
Growth and Survival of Bagged Lucilia sericata Maggots in Wounds of Patients Undergoing Maggot Debridement Therapy
Table 2
Survival and development of L. sericata larvae in wounds of different etiology.
| | Wound type |
Mean (95% CI) survival (%) of maggots following MDT cycle of |
Mean (range) proportion (%) of second instars among all larvae following MDT cycle of | | 48 hours | 72 hours | 48 hours | 72 hours |
| | Traumatic | 72.8 (0.0–100.0) | — | 0.6 (0.0–1.1) | — | | Ischemic | 79.1 (68.3–88.6) | — | 0.8 (0.0–2.4) | — | | Venous | 63.6 (0.0–92.1) | 55.9 (27.0–74.4) | 7.3 (1.4–20.0) | 0.7 (0.0–3.2) | | Diabetic | 82.7 (69.4–94.2) | 74.7 (68.9–80.1) | 0.7 (0–1.7) | 0.6 (0.0–2.5) |
|
|
Confidence interval.
|